✦ LIBER ✦

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

✍ Scribed by Youjin Je; Fabio AB Schutz; Toni K Choueiri

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tyrosine Kinase Inhibitors of Vascular E

✍ Morabito, A.; De Maio, E.; Di Maio, M.; Normanno, N.; Perrone, F. 📂 Article 📅 2006 🏛 Alphamed Press 🌐 English ⚖ 286 KB

Risks of Proteinuria and Hypertension Wi

✍ Xiaolei Zhu; Shenhong Wu; William L. Dahut; Chirag R. Parikh 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 409 KB

The risk of nail changes with epidermal

✍ Garden, Benjamin C.; Wu, Shenhong; Lacouture, Mario E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 648 KB

Efficacy and safety of vascular endothel

✍ Jae-Lyun Lee; Inkeun Park; Kwonoh Park; Seongjoon Park; Yongcheol Ahn; Jin-Hee A 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 317 KB

Epidermal growth factor receptor mutatio

✍ Xiao-Hang Zhang; Cheng Li; Chen-Fei Dai; Bao-Sen Zhou 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 203 KB

YN968D1 is a novel and selective inhibit

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB